The modern logo is seen on 9 April 2025 in Warsaw, Poland.
Jakub porzycki | Nurphoto | Getty images
Moderna The delay in vaccine shipment in the UK on Friday reduced the high end of its 2025 revenue approach, but defeated Wall Street’s hopes for the second quarter as it works to cut the cost.
Modern shares fell more than 6% in premarket trading on Friday.
The Biotech company now expects a full year revenue between $ 1.5 billion and $ 2.2 billion below $ 300 million at the top of that range. Results come a day after modern 10% slash of your workforceThe company struggles with the sale of covid vaccine by adding a string of cost cuts and tries to bring more products to the market.
In an interview, modern CFO Jamie Mock said that the company will send those jabs to the country in the first quarter of 2026 instead of spring covid booster shipping in the UK later this year. He said that there has been no change in the overall contract price between modern and UK.
Mock said, “It has been taking delivery at the end of our financial year from the end of our financial year, which is the first quarter of next year, to complete the supply for the spring booster in the UK,” Mock said.
In addition, on Friday, the company said it was less lost than analysts, expecting for the second quarter and posted revenue which were at the top of estimates.
Here the modern told what for the second quarter what Wall Street was expecting, based on a survey of analysts by LSEG:
- Per share loss: Expected loss of $ 2.13 vs $ 2.97
- Income: $ 142 million vs $ 113 million is expected
Modern posted a second quarter sales of $ 142 million with a decline of 41% from the same period a year ago due to the sale of Covid vaccine. Most of the second quarter revenue came from its covid shot, which took $ 114 million for this period.
According to Strikint’s estimates, analysts expected this period.
Strikount estimates stated that the company stated that its vaccine for the respiratory synchronous virus was “negligible” sales, compared to $ 5.9 million analysts expected.
The company posted a net deficit of $ 825 million for the second quarter, or $ 2.13 per share. It compares with a net deficit of $ 1.3 billion, or a report for a period of year-first, per share.
Mock said modern efforts to cut costs defeated the company for the quarter. He said that during the same period a year ago, the company’s second-quarter operating expenses fell by 27% to $ 1.1 billion to $ 1.1 billion.
“If there is anything really to read from the first half [of 2025] Concerned, from a financial perspective, it is on the cost side, “Mock said.
